Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1311022.RABcZXqcKngudhVYEfHTKyiXhA9gsGV0K-McLv_G-2ejM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1311022.RABcZXqcKngudhVYEfHTKyiXhA9gsGV0K-McLv_G-2ejM130_assertion type Assertion NP1311022.RABcZXqcKngudhVYEfHTKyiXhA9gsGV0K-McLv_G-2ejM130_head.
- NP1311022.RABcZXqcKngudhVYEfHTKyiXhA9gsGV0K-McLv_G-2ejM130_assertion description "[To facilitate studies directed at investigating this issue, androgen receptor-negative (AR-) PC3 prostate carcinoma cells were stably transfected with the expression plasmid CMV3 containing a constitutively active AR construct that is truncated at its hormone-binding domain (CMV-ARCA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311022.RABcZXqcKngudhVYEfHTKyiXhA9gsGV0K-McLv_G-2ejM130_provenance.
- NP1311022.RABcZXqcKngudhVYEfHTKyiXhA9gsGV0K-McLv_G-2ejM130_assertion evidence source_evidence_literature NP1311022.RABcZXqcKngudhVYEfHTKyiXhA9gsGV0K-McLv_G-2ejM130_provenance.
- NP1311022.RABcZXqcKngudhVYEfHTKyiXhA9gsGV0K-McLv_G-2ejM130_assertion SIO_000772 7532576 NP1311022.RABcZXqcKngudhVYEfHTKyiXhA9gsGV0K-McLv_G-2ejM130_provenance.
- NP1311022.RABcZXqcKngudhVYEfHTKyiXhA9gsGV0K-McLv_G-2ejM130_assertion wasDerivedFrom befree-2016 NP1311022.RABcZXqcKngudhVYEfHTKyiXhA9gsGV0K-McLv_G-2ejM130_provenance.
- NP1311022.RABcZXqcKngudhVYEfHTKyiXhA9gsGV0K-McLv_G-2ejM130_assertion wasGeneratedBy ECO_0000203 NP1311022.RABcZXqcKngudhVYEfHTKyiXhA9gsGV0K-McLv_G-2ejM130_provenance.